The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 19th 2025
Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.
Inhaled siRNA-Based MIR 19 Reduces Progression to Severe Disease in Outpatients With Mild COVID-19
April 16th 2025With a more direct mechanism of action against viral replication compared with standard treatments, the small interfering RNA (siRNA)-based MIR 19 treatment could revolutionize outpatient COVID-19 treatment.
Read More
AZD0780, Novel Oral PCSK9 Inhibitor, Demonstrates Major LDL Cholesterol Reductions
April 11th 2025When used in combination with background statin therapy, AZD0780 resulted in major reductions in low-density lipoprotein cholesterol (LDL-C) and achievements of guideline-recommended LDL-C goals.
Read More
Financial Incentives for COVID-19 Vaccination May Have Adverse Spillover Effects on Booster Uptake
April 9th 2025Monetary incentives to receive a COVID-19 vaccine at a public vaccination event may have inadvertently turned away others from receiving a booster, emphasizing the importance of recognizing spillover in trials addressing vaccine hesitancy.
Read More
Long-Term Tirzepatide Demonstrates Benefits in Patients With CKD, Obesity, and HFpEF
April 7th 2025Tirzepatide-treated patients with chronic kidney disease (CKD), obesity, and heart failure with preserved ejection fraction (HFpEF) had improved renal function both by cystatin C and creatinine.
Read More